Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | MTOR | P42345 | 1/20 | 0.37 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.37 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.37 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.37 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.35 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.35 |
| ▸ | ALB | P02768 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.35 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.35 |
| ▸ | FGFR1 | P11362 | 2/20 | 0.35 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.35 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8743705 | 0.84 | CRBN (0.36) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL7016369 | 0.81 | HTR6 (0.37) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL24672711 | 0.74 | CRBN (0.32) | LMNATHRBMTORMDM2NCOA1 | |
| SCHEMBL7016019 | 0.73 | L3MBTL1 (0.50) | LMNAMAPTCRBNL3MBTL1HTR6 | |
| SCHEMBL22016090 | 0.69 | — | — | |
| SCHEMBL25378286 | 0.69 | — | — | |
| SCHEMBL11894064 | 0.69 | — | — | |
| SCHEMBL8790826 | 0.67 | — | — | |
| SCHEMBL8944773 | 0.67 | — | — | |
| SCHEMBL19692381 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091048-A1 | METHODS AND COMPOSITIONS FOR DETECTING GENETIC MATERIAL | BIO-RAD LABORATORIES, INC. | 2025-03-20 | — | — | US | disclosed |
| US-12097495-B2 | Methods and compositions for detecting genetic material | BIO-RAD LABORATORIES, INC. (US) | 2024-09-24 | — | — | US | disclosed |
| CN-117089607-A | Single cell RNA m 5 Analysis method for C modification | 中国科学院北京基因组研究所(国家生物信息中心) | 2023-11-21 | — | — | CN | disclosed |
| WO-2023217214-A1 | METHOD FOR ANALYZING RNA M5C MODIFICATION IN SINGLE CELLS | 中国科学院北京基因组研究所(国家生物信息中心) | 2023-11-16 | — | — | WO | disclosed |
| US-20220362764-A1 | METHODS AND COMPOSITIONS FOR DETECTING GENETIC MATERIAL | BIO-RAD LABORATORIES, INC. (US) | 2022-11-17 | — | — | US | disclosed |
| US-20220157469-A1 | METHODS OF PREDICTING AGE, AND IDENTIFYING AND TREATING CONDITIONS ASSOCIATED WITH AGING USING SPECTRAL CLUSTERING AND DISCRETE COSINE TRANSFORM | SERAGON PHARMACEUTICALS, INC. | 2022-05-19 | — | — | US | disclosed |
| US-20220136037-A1 | METHODS OF PREDICTING AGE, AND IDENTIFYING AND TREATING CONDITIONS ASSOCIATED WITH AGING | SERAGON PHARMACEUTICALS, INC. | 2022-05-05 | — | — | US | disclosed |
| US-20140357497-A1 | DESIGNING PADLOCK PROBES FOR TARGETED GENOMIC SEQUENCING | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2014-12-04 | — | — | US | disclosed |
| US-20140295445-A1 | Method for the Carry-Over Protection in DNA Amplification Systems Targeting Methylation Analysis Achieved by a Modified Pre-Treatment of Nucleic Acids | EPIGENOMICS AG (DE) | 2014-10-02 | — | — | US | disclosed |
| US-8753810-B2 | Method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids | EPIGENOMICS AG (DE) | 2014-06-17 | — | — | US | disclosed |
| EP-1659186-B1 | A method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids | EPIGENOMICS AG (DE) | 2008-05-21 | — | — | EP | disclosed |
| WO-2008047234-A1 | A MOLECULE FOR PROVIDING A STANDARD FOR THE QUANTITATIVE ANALYSIS OF THE METHYLATION STATUS OF A NUCLEIC ACID | EPIGENOMICS AG (DE) | 2008-04-24 | — | — | WO | disclosed |
| US-20080096199-A1 | Protecting preferential amplification products via cytosine sulfonation; using methylation pattern to diagnose disease | EPIGENOMICS AG (DE) | 2008-04-24 | — | — | US | disclosed |
| US-20080064043-A1 | Method for detecting a methylation pattern | EPIGENOMICS AG (DE) | 2008-03-13 | — | — | US | disclosed |
| EP-1882746-A2 | Method for detecting a methylation pattern | Epigenomics AG (DE) | 2008-01-30 | — | — | EP | disclosed |
| EP-1882747-A1 | A method for the analysis of the methylation status of a nucleic acid | Epigenomics AG (DE) | 2008-01-30 | — | — | EP | disclosed |
| WO-2008009365-A2 | A METHOD FOR DETERMINING THE METHYLATION RATE OF A NUCLEIC ACID | EPIGENOMICS AG (DE) | 2008-01-24 | — | — | WO | disclosed |
| WO-2007141034-A1 | CARRY-OVER PROTECTION IN ENZYME-BASED DNA AMPLIFICATION SYSTEMS TARGETING METHYLATION ANALYSIS | EPIGENOMICS AG (DE) | 2007-12-13 | — | — | WO | disclosed |
| US-20060115835-A1 | Protecting preferential amplification products via cytosine sulfonation; using methylation pattern to diagnose disease | EPIGENOMICS AG (DE) | 2006-06-01 | — | — | US | disclosed |
| EP-1659186-A1 | A method for the carry-over protection in DNA amplification systems targeting methylation analysis achieved by a modified pre-treatment of nucleic acids | Epigenomics AG (DE) | 2006-05-24 | — | — | EP | disclosed |